Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Cabrera, Susanne M; Wang, Xujing; Chen, Yi-Guang; Jia, Shuang; Kaldunski, Mary L; Greenbaum, Carla J; Type 1 Diabetes TrialNet Canakinumab Study Group; Mandrup-Poulsen, Thomas; AIDA Study Group; Hessner, Martin J (2016). Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset. European Journal of Immunology, 46(4):1030-1046.

Moran, Antoinette; Bundy, Brian; Becker, Dorothy J; DiMeglio, Linda A; Gitelman, Stephen E; Goland, Robin; Greenbaum, Carla J; Herold, Kevan C; Marks, Jennifer B; Raskin, Philip; Sanda, Srinath; Schatz, Desmond; Wherrett, Diane K; Wilson, Darrell M; Krischer, Jeffrey P; Skyler, Jay S; Pickersgill, Linda; de Koning, Eelco; Ziegler, Anette-G; Böehm, Bernhard; Badenhoop, Klaus; Schloot, Nanette; Bak, Jens Friis; Pozzilli, Paolo; Mauricio, Didac; Donath, Marc Y; Castaño, Luis; Wägner, Ana; Lervang, Hans Henrik; Perrild, Hans; Mandrup-Poulsen, Thomas (2013). Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet, 381(9881):1905-1915.

Pham, Minh Nguyet; Kolb, Hubert; Mandrup-Poulsen, Thomas; Battelino, Tadej; Ludvigsson, Johnny; Pozzilli, Paolo; Roden, Michael; Schloot, Nanette C (2013). Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin. Diabetes/Metabolism Research and Reviews, 29(2):166-170.

Larsen, Claus M; Faulenbach, Mirjam; Vaag, Allan; Vølund, Aage; Ehses, Jan A; Seifert, Burkhardt; Mandrup-Poulsen, Thomas; Donath, Marc Y (2007). Interleukin-1-receptor antagonist in type 2 diabetes mellitus. New England Journal of Medicine, 356(15):1517-1526.

Larsen, Claus Morten; Faulenbach, Mirjam; Vaag, Allan; Vølund, Aage; Ehses, Jan; Seifert, Burkhardt; Mandrup-Poulsen, Thomas; Donath, Marc (2007). Interleukin-1 receptor antagonist-treatment of patients with type 2 diabetes. Ugeskrift for laeger, 169(45):3868-3871.

Mandrup-Poulsen, Thomas; Seifert, Burkhardt; Donath, Marc Y (2007). Interleukin-1-receptor antagonist in type 2 diabetes mellitus: the authors reply. New England Journal of Medicine, 357(3):303.

Donath, Marc Y; Störling, Joachim; Maedler, Kathrin; Mandrup-Poulsen, Thomas (2003). Inflammatory mediators and islet ?-cell failure: a link between type 1 and type 2 diabetes. Journal of Molecular Medicine, 81(8):455-470.

This list was generated on Fri Aug 23 03:34:19 2019 CEST.